The FTSE 100 on Thursday closed up 0.3% despite the European
Central Bank raising interest rates, says Chris Beauchamp, chief
market analyst at online trading platform IG. The ECB has put
investors on notice that the new policy of sharp interest-rate
hikes is here to stay for a while, Beauchamp says. The FTSE 100's
top risers were Antofagasta PLC, Pershing Square Holdings Ltd. and
Standard Chartered PLC, while the session's top fallers were
Melrose Industries PLC, Associated British Foods PLC and B&M
European Value Retail SA.
FTSE 100 Gains Ahead of European Central Bank Decision
0828 GMT - The FTSE 100 Index gains 0.3%, or 21 points to 7259
as oil, mining and financial stocks rise ahead of the European
Central Bank's rate-setting decision at 1215 GMT. BHP, Antofagasta
and Rio Tinto advance as metal prices mostly increase, while BP and
Shell climb as Brent crude advances 0.4% to $88.36 a barrel. Banks
and insurers also gain amid speculation that the ECB will boost
eurozone interest rates by 75 basis points. Still, Primark owner
Associated British Foods drops 7% and rivals fall after ABF said it
now expected Primark's profit margin for next year to be lower than
the operating profit margin of 8.0% forecast for the second half of
this financial year, which ends on Sept. 17.
(philip.waller@wsj.com)
Companies News:
Thoma Bravo Doesn't Plan to Make an Offer for Darktrace
Thoma Bravo LLC said Thursday that it doesn't plan to make a
formal offer for Darktrace PLC, without providing any explanation
as to why.
---
DCC To Buy Medi-Globe Technologies
DCC said Thursday that its healthcare division has agreed to
acquire the medical devices business Medi-Globe Technologies
GmbH.
---
Darktrace Swung to FY 2022 Pretax Profit, Revenue Rose on
Growth
Darktrace PLC said Thursday that it swung to a pretax profit for
fiscal 2022 on increased revenue as it saw a rise in customer
numbers.
---
Associated British Foods Sees FY 2022 Adjusted Profit Rising on
Sales Growth
Associated British Foods PLC said Thursday that its fiscal 2022
adjusted operating profit and adjusted earnings per share are
expected to surpass the previous year's on strong sales growth, and
that it anticipates rising sales, but declining profit, in fiscal
2023.
---
Vistry 1H Pretax Profit Slipped on Cladding Costs; Backs FY 2022
Profit View
Vistry Group PLC said Thursday that pretax profit slipped for
the first half of 2022 on exceptional costs related to building
safety remediation, though revenue rose and it backed its full year
expectations.
---
Melrose Industries 1H Pretax Loss Widened, Missed Forecast; To
Demerge Two Businesses
Melrose Industries PLC said Thursday that its first-half pretax
loss widened and missed a forecast after it booked higher costs,
and that it intends to separate the GKN automotive and GKN powder
metallurgy businesses via a demerger.
---
Funding Circle 1H Pretax Profit Fell, Cuts 2H Income Outlook
Funding Circle Holdings PLC said Thursday that pretax profit
sharply fell in the first half 2022 and downgraded its income
outlook for the second half, citing macro uncertainties.
---
Restaurant Group 1H Pretax Loss Narrowed as Revenue
Increased
Restaurant Group PLC said Thursday that its pretax loss for the
first half of 2022 narrowed as revenue rose significantly.
---
Warpaint London Raises 2022 Views on Strong Performance
Warpaint London PLC said Thursday that strong first-half trading
has continued into the second half of 2022 and it now expects
full-year results to be ahead of market expectations.
---
National Express Names Helen Weir as Next Chairwoman, James
Stamp as Interim CFO
National Express Group PLC said Thursday that Helen Weir will be
its next chairwoman, replacing current chairman John Armitt, and
that James Stamp will be appointed interim chief financial officer
on Nov. 1.
Market Talk:
Darktrace Hit by Thoma Bravo Talks Ending
0905 GMT - Thoma Bravo's decision not to make a bid for
Darktrace is clearly an outcome that will weigh on the U.K.
cybersecurity company as the bidder is a reasonably well-respected
enterprise software investor, Davy Research's David Reynolds and
Alex Short say in a research note. Darktrace's full-year results
were solid, but a revenue recognition issue that took around $3.8
million in fiscal 2022 revenue into the prior year is probably not
a positive in terms of investor confidence, Reynolds and Short say.
This is though perhaps trivial when compared with the talks ending,
they add. Shares are down 30% at 358.00 pence.
(kyle.morris@dowjones.com)
Vistry's 1H Sparks Cheer, But Market Clouds Gather
0904 GMT - Vistry Group rises 1% and other U.K. house builders
gain after the company formerly known as Bovis Homes reported
higher first-half adjusted pretax profit and backed its full-year
expectations. Still, news elsewhere in the sector were more
downbeat, with a Royal Institution of Chartered Surveyors market
survey showing a balance of 53 respondents reporting higher house
prices in August, down from 62 in July and representing the weakest
reading since January 2021, Interactive Investor says. "Fears of an
upcoming recession, spiraling inflation, rising interest rates and
the cost-of-living crisis are starting to impact the housing
market, with buyers and sellers potentially holding off amid the
uncertainty," Interactive head of investment Victoria Scholar says
in a note. (philip.waller@wsj.com)
GSK's Uncertainty Overhangs Are Persisting
0900 GMT - GSK shares reflect the worst-case scenario around the
litigation over Zantac, a recalled heartburn drug, Jefferies
analysts say in a note. That scenario, however, can't be excluded
as unreasonable, and the company's uncertainty overhang is
persisting, perhaps until the second half of 2023, they say as they
downgrade the stock to hold from buy. If a settlement is reached
over Zantac, plaintiffs would negotiate between themselves to agree
the proportion owed by each company involved in the case, and GSK
is likely to be the most exposed company, the analysts say. The
British major's share of the settlement might reach 30% or 50%,
according to Jefferies. (cecilia.butini@wsj.com)
Melrose Business Demerger Will Deliver Significant Upside
0835 GMT - Melrose Industries demerging its automotive and
powder metallurgy businesses will allow both independent groups to
benefit from a simpler, focused structure and deliver significant
upside in both revenue and margins, J.P. Morgan Cazenove analysts
Andrew Wilson and Chitrita Sinha say in a note. The turnaround
specialist's timing is appropriate, allowing for suitable capital
structures for both groups, while a restructuring of the automotive
business is already complete, they say. "The rationale is clear;
Melrose Group will be able to actively pursue its 'Buy, Improve,
Sell' model in Aerospace or broader industrial opportunities, while
Automotive Group will be able to take advantages of auto-specific
opportunities, potentially acting as a consolidator in the
industry," the analysts say.
(anthony.orunagoriainoff@dowjones.com)
Contact: London NewsPlus; paul.larkins@wsj.com
(END) Dow Jones Newswires
September 08, 2022 12:09 ET (16:09 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Associated British Foods (PK) (USOTC:ASBFY)
Historical Stock Chart
From Dec 2024 to Jan 2025
Associated British Foods (PK) (USOTC:ASBFY)
Historical Stock Chart
From Jan 2024 to Jan 2025